Replies to post #13286 on BioCurex, Inc.(fka BOCX)

[xkzuma]

So what's your feel on the probability of getting a 3rd licensee lined up to commence trials? IMA got slapped with
no fewer then 3 class-action suits in the last week so you've gotta wonder about their focus on RECAF right now. As promising as it appears, there just seems to be a huge disconnect as to why BOCX can't get any damn traction in getting RECAF commercialized. Something just doesn't seem to add up to me at this point.